Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of PAP Therapy on Reducing AF Recurrence in Patients With Morbidity of OSA: a Clinical Randomized Control Trial

NCT04519489 is registered in ClinicalTrials.gov with Philips (China) Investment CO., LTD as lead sponsor.

NCT NCT04519489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04519489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of PAP Therapy on Reducing AF Recurrence in Patients With Morbidity of OSA: a Clinical Randomized Control Trial
Lead sponsor
Philips (China) Investment CO., LTD
Phase
Not applicable
Overall status
Terminated
Start date
September 18, 2020
Completion date
December 24, 2021
Enrollment
129 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, obstructive sleep apnea